Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 March 2006

Gut. Published Online First: 8 September 2005. doi:10.1136/gut.2005.075002
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Paper

Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

Cristina Rigamonti 1, Lynne M Shand 2, Maurille Feudjo 3, Chris C Bunn 2, Carol M Black 2, Christopher P Denton 2 and Andrew K Burroughs 1*

1 Royal Free Hospital, Liver Transplantation and Hepatobiliary Medicine, United Kingdom
2 Royal Free Hospital, Centre for Rheumatology, United Kingdom
3 London School of Hygiene and Tropical Medicine, Medical Statistics Unit, United Kingdom

* To whom correspondence should be addressed. E-mail: andrew.burroughs{at}royalfree.nhs.uk.

Accepted 31 August 2005


Abstract

Backgrounds and aims: To evaluate the prognosis of primary biliary cirrhosis (PBC) together with systemic sclerosis (SSc), as this is unknown.

Methods and results: A PBC database of 580 patients identified 43 with PBC and SSc: 2 patients with PBC alone were matched to each PBC-SSc patient for serum bilirubin concentration at the initial visit. Forty (93%) had limited cutaneous SSc. At diagnosis of PBC median values were: 49.7 years, bilirubin 17 µ mol/L, albumin 40.5 g/L. The liver diagnosis occurred a median 4.9 years after SSc in 24 (56%). In matched patients, median values at diagnosis were: 53.2 years, bilirubin 12 µmol/L, albumin 41 g/L. Median follow-up was similar: 3.16 years (PBC-SSc), 4.8 years (PBC alone). The risk of transplantation or death from diagnosis, adjusting for sex, age, log bilirubin and alkaline phosphatase, was significantly lower in PBC-SSc (hazard ratio 0.116, P=0.01), due to less transplantation (hazard ratio 0.068, P=0.006). The rate of bilirubin increase was less in PBC-SSc (P=0.04). Overall survival was similar (hazard ratio 1.11, P=0.948); deaths: 9 (21%) in PBC-SSc (6 SSc-related and 2 liver-related), 9 (11%) in PBC alone (6 liver-related).

Conclusions: Liver disease has a slower progression in PBC-SSc, compared to matched patients with PBC alone.

Keywords: anticentromere antibody, antimitochondrial antibody, autoimmune disease, liver transplantation, survival


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Digest
Robin Spiller and Alastair Watson
Gut 2006 55: 297. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • ASSASSI, S., FRITZLER, M. J., ARNETT, F. C., NORMAN, G. L., SHAH, K. R., GOURH, P., MANEK, N., PERRY, M., GANESH, D., RAHBAR, M. H., MAYES, M. D. (2009). Primary Biliary Cirrhosis (PBC), PBC Autoantibodies, and Hepatic Parameter Abnormalities in a Large Population of Systemic Sclerosis Patients. The Journal of Rheumatology 36: 2250-2256 [Abstract] [Full Text]  
  • (2007). Biliary cirrhosis associated with systemic sclerosis. Ann Rheum Dis 66: 120-120 [Full Text]  

eLetters:

Read all eLetters

Prognosis of Primary Biliary Cirrhosis in Japanese Systemic Sclerosis Patients
Norihito Yazawa, et al.
Gut Online, 18 May 2006 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs